HomeANIX • NASDAQ
add
Anixa Biosciences Inc
Previous close
$3.19
Day range
$3.06 - $3.16
Year range
$2.33 - $5.46
Market cap
103.15M USD
Avg Volume
439.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.88M | -9.07% |
Net income | -2.70M | 6.52% |
Net profit margin | — | — |
Earnings per share | -0.09 | 0.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.17M | -23.84% |
Total assets | 16.08M | -25.52% |
Total liabilities | 2.13M | -21.20% |
Total equity | 13.95M | — |
Shares outstanding | 33.38M | — |
Price to book | 6.93 | — |
Return on assets | -42.63% | — |
Return on capital | -48.29% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2025info | Y/Y change |
|---|---|---|
Net income | -2.70M | 6.52% |
Cash from operations | -1.26M | -35.38% |
Cash from investing | 654.00K | -24.57% |
Cash from financing | 350.00K | 230.19% |
Net change in cash | -251.00K | -645.65% |
Free cash flow | -271.50K | -208.11% |
About
Founded
1982
Headquarters
Website
Employees
4
